Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Hairline International Unveils Rigenera Activa – A Procedure for Autologous Skin Micrografting, for the first ime in India - The Pharma Times | Pharma & Health Care News Portal

Hairline International Unveils Rigenera Activa – A Procedure for Autologous Skin Micrografting, for the first ime in India

Bangalore, April 12, 2018: Hairline International Hair and Skin Clinic has been working tirelessly in the field of regenerative therapies for hair and skin and is today proud to unveil RigeneraActiva, a specialized technology imported from Italy to launch autologous skin micrografting in the treatment of male and female pattern hair loss for the first time in India.

This therapy makes use of tissue from a patient to create an ideal cocktail of growth enhancement cells that is introduced into the scalp or the skin to encourage hair growth. The process involves just one sitting and results can be seen as early as within a month.RigeneraActiva is approved by the US FDA, Japan’s PMPD and is CE certified.

Speaking at the unveiling of RigeneraActiva, Dr. BaniAnand, Founder and Director, Hairline International Hair and Skin Clinic says, “This is a standalone procedure and can be used for treating hair loss up to Grade 4. For skin, the process of injecting takes about 20 minutes and the recovery time is around half hour, making it an ideal procedure. The procedure itself is completed in one sitting of not more than 30 minutes and results can be seen as early as within a month. Follow-ups are required just once a year for a short while. This procedure works for anyone above 21 years of age”.

Explaining the procedure that is scientifically known as stromal vascular fraction, Dr. Dinesh G Gowda, Senior Dermato-surgeon, Hairline International Hair and Skin Clinic explains, “Whether for hair or for skin, the epidermal layer is removed and around 2mm of the patient’s own tissuefrom the dermis, including fat is taken out. This tissue contains many growth factors and progenitor cells among other components. This is pulverized in a specialized machine and then is subject to filtration using a biological filter. This separates the progenitor cells, growth factors such as endothelial growth factors, fibroblast hair follicles etc.,which support hair follicles and skin cells – for growth as well as formation of new hair follicles and skin cells”.

Dr. Gowda adds that this cocktail of growth enhancers is injected via a thin needle into the scalp or the skin at areas needed. The process may be repeated in a year if needed for skin and if one would like a dense growth of hair.

Elaborating on the benefits of such a process, Dr. Gowda explains, “While hair transplant remains the best form of therapy, this therapy makes use of the patient’s own tissue to create an effective cocktail and works better than individual growth factors which are used. This therapy may be used alone or with hair transplant. It may be used with PRP as well.

Some other beneficial applications of the therapy are in the treatment of scars, Vitiligo, wound healing and face rejuvenation as well and stretch marks”.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

2 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

4 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago